The impact of gut microbiota on insulin resistance in polycystic ovary syndrome: mechanisms and therapeutic prospects
Frontiers in Cellular and Infection Microbiology · 19.08.2026 · 16
DOI: 10.3389/fcimb.2026.1840605 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 19.08.2026. Verfasst von Yifan Gao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, Sichuan, China. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Insulin Resistance, Gastrointestinal Microbiome. Die Arbeit nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Polycystic ovary syndrome (PCOS) is a prevalent endocrine and metabolic disorder, with insulin resistance (IR) serving as its core pathophysiological feature and a key driver of long-term metabolic complications. Recent studies have revealed that the gut microbiota, as a critical environmental factor, plays a significant role in the pathogenesis of PCOS. The gut microbiota profoundly engages in the pathophysiology of PCOS-IR through multiple pathways and networked interactions. This review provides a comprehensive narrative synthesis of the latest evidence on gut microbiota dysbiosis in PCOS-IR, with a particular focus on its molecular mechanisms, and evaluates therapeutic strategies based on gut microbiota modulation. It seeks to provide theoretical foundations and forward-looking perspectives for precision microbiome therapies. Importantly, this is a narrative review with a mechanistic focus, rather than a formal systematic review or meta-analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecology, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, Sichuan, China.
Zitieren
APA
Gao, Y., Liu, C., & He, X. (2026). The impact of gut microbiota on insulin resistance in polycystic ovary syndrome: mechanisms and therapeutic prospects. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1840605
Vancouver
Gao Y, Liu C, He X. The impact of gut microbiota on insulin resistance in polycystic ovary syndrome: mechanisms and therapeutic prospects. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1840605
BibTeX
@article{Gao2026,
author = {Gao, Yifan and Liu, Ciyan and He, Xiaoxia},
title = {The impact of gut microbiota on insulin resistance in polycystic ovary syndrome: mechanisms and therapeutic prospects},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1840605}
}
EUVIMED